The surge in demand for GLP-1 agonists (semaglutide and tirzepatide) has put peptide therapy into mainstream conversation but many patients arrive without a clear picture of how GLP-1s compare to other peptides, or what a supervised program actually looks like
Standardization of measurement techniques, reporting of important patient characteristics such as disease severity, onset, and duration, as well as concomitant illnesses and medications, and additional studies in MCI would allow for better characterization of early biomarkers changes in different stages of cognitive impairment
It supports gut health, protects against NSAID damage, and promotes recovery from various types of tissue injury
Nare B, Smith JM and Prichard RK
But for these reasons, natural products and their derivatives should be used cautiously in patients with monitoring for signs of toxicity
The two compounds act on different systems pharmacologically